Page last updated: 2024-11-05

thalidomide and Lower Urinary Tract Symptom

thalidomide has been researched along with Lower Urinary Tract Symptom in 1 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Tamalunas, A1
Sauckel, C1
Ciotkowska, A1
Rutz, B1
Wang, R1
Huang, R1
Li, B1
Stief, CG1
Gratzke, C1
Hennenberg, M1

Other Studies

1 other study available for thalidomide and Lower Urinary Tract Symptom

ArticleYear
Inhibition of human prostate stromal cell growth and smooth muscle contraction by thalidomide: A novel remedy in LUTS?
    The Prostate, 2021, Volume: 81, Issue:7

    Topics: Apoptosis; Cell Line; Cell Proliferation; Cell Survival; Humans; Lower Urinary Tract Symptoms; Male;

2021